Expression of γH2AX in various gastric pathologies and its association with Helicobacter pylori infection

Oncology Letters

Volumn 7, Issue 1, 2014, Pages 159-163

  Xie, Chuan ^a   Xu, Li Yao ^a   Yang, Zhen ^a   Cao, Xi Mei ^a   Li, Wei ^a   Lu, Nong Hua ^a  

^a NANCHANG UNIVERSITY   (China)

Author keywords

H2AX; DNA double strand breaks; Gastric carcinogenesis; Helicobacter pylori

Indexed keywords

HISTONE H2AX;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER GROWTH; CHRONIC GASTRITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DOUBLE STRANDED DNA BREAK; DYSPLASIA; FEMALE; HELICOBACTER INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; INTESTINE METAPLASIA; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; STOMACH BIOPSY; STOMACH CANCER; STOMACH CARCINOGENESIS; WESTERN BLOTTING;

EID: 84888413977     PISSN: 17921074     EISSN: 17921082     Source Type: Journal    
DOI: 10.3892/ol.2013.1693     Document Type: Article

References (18)

1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C and Parkin DM: Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127: 2893-2917, 2010.
2. Correa P: Human gastric carcinogenesis: a multistep and multifactorial process-First American Cancer Society Award Lecture on Cancer Epidemiology and Prevention. Cancer Res 52: 6735-6740, 1992.
3. Toller IM, Neelsen KJ, Steger M, Hartung ML, Hottiger MO, Stucki M, et al: Carcinogenic bacterial pathogen Helicobacter pylori triggers DNA double-strand breaks and a DNA damage response in its host cells. Proc Natl Acad Sci USA 108: 14944-14949, 2011.
4. Jang SH, Lim JW, Morio T and Kim H: Lycopene inhibits Helicobacter pylori-induced ATM/ATR-dependent DNA damage response in gastric epithelial AGS cells. Free Radic Biol Med 52: 607-615, 2012.
5. Smith J, Tho LM, Xu N and Gillespie DA: The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 108: 73-112, 2010.
6. Sharma A, Singh K and Almasan A: Histone H2AX phosphorylation: a marker for DNA damage. Methods Mol Biol 920: 613-626, 2012.
7. Matthaios D, Foukas PG, Kefala M, Hountis P, Trypsianis G, Panayiotides IG, et al: γ-H2AX expression detected by immunohistochemistry correlates with prognosis in early operable non-small cell lung cancer. Onco Targets Ther 5: 309-314, 2012.
8. Brustmann H, Hinterholzer S and Brunner A: Immunohistochemical expression of survivin and γ-H2AX in vulvar intraepithelial neoplasia and low-stage squamous cell carcinoma. Int J Gynecol Pathol 30: 583-590, 2011.
9. Nagelkerke A, van Kuijk SJ, Sweep FC, Nagtegaal ID, Hoogerbrugge N, Martens JW, et al: Constitutive expression of γ-H2AX has prognostic relevance in triple negative breast cancer. Radiother Oncol 101: 39-45, 2011.
10. Sentani K, Oue N, Sakamoto N, Nishisaka T, Fukuhara T, Matsuura H and Yasui W: Positive immunohistochemical staining of gammaH2AX is associated with tumor progression in gastric cancers from radiation-exposed patients. Oncol Rep 20: 1131-1136, 2008.
11. Hamilton SR and Aaltonen LA (eds): Pathology and genetics of tumours of the digestive system. In: World Health Organization Classification of Tumours. IARC Press, Lyon, 2000.
12. Dixon MF, Genta RM, Yardley JH and Correa P: Classification and grading of gastritis. The updated Sydney System. International Workshop on the Histopathology of Gastritis, Houston 1994. Am J Surg Pathol 20: 1161-1181, 1996.
13. Yang Z, Shu X, Chen L, Chen J, Xie Y and Lu NH: Expression of p53-MDM2 feedback loop related proteins in different gastric pathologies in relation to Helicobacter pylori infection: implications in gastric carcinogenesis. Clin Res Hepatol Gastroenterol 36: 235-243, 2012.
14. Yang Z, Yuan XG, Chen J, Luo SW, Luo ZJ and Lu NH: Reduced expression of PTEN and increased PTEN phosphorylation at residue Ser380 in gastric cancer tissues: a novel mechanism of PTEN inactivation. Clin Res Hepatol Gastroenterol 37: 72-79, 2013.
15. van Gent DC, Hoeijmakers JH and Kanaar R: Chromosomal stability and the DNA double-stranded break connection. Nat Rev Genet 2: 196-206, 2001.
16. Bartkova J, Horejsí Z, Koed K, Krämer A, Tort F, Zieger K, et al: DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature 434: 864-870, 2005.
17. Martin RW, Orelli BJ, Yamazoe M, Minn AJ, Takeda S and Bishop DK: RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors. Cancer Res 67: 9658-9665, 2007.
18. Martin RW, Connell PP and Bishop DK: The Yin and Yang of treating BRCA-deficient tumors. Cell 132: 919-920, 2008.